Search…

New Stock News | Minyu Pharmaceutical Resubmits Application to Hong Kong Stock Exchange, Its own Immunotherapy Project Expected to Generate Revenue Soon.

09/07/2026

According to the Zhitong Financial APP, as disclosed by the Hong Kong Stock Exchange on July 8, Mingyu Pharmaceutical Co., Ltd.-B (referred to as Mingyu Pharmaceutical) has once again submitted its application for listing on the main board of the Hong Kong Stock Exchange. Morgan Stanley, BofA Securities, and CITIC Securities are its joint sponsors.

Latest

2 m ago

The total market value of Duck King Holdings Limited (02250.HK) stored in the warehouse is 36.4 million Hong Kong dollars. Shareholders have deposited 140 million shares of stock with Huaye Securities.

2 m ago

Jingjiu kang therapy (00648.HK) transferred the total market value of 7.9257 million Hong Kong dollars, accounting for 9.13%. Shareholders transferred 3.7573 million shares from Citibank.

4 m ago

Ministry of Commerce and 9 other departments: Encourage retail operators to stabilize their workforce, use more labor contracts, and improve employee benefits.

4 m ago

C-LINK SQ (01463) transferred a total market value of 1.54 billion Hong Kong dollars, accounting for 18.11% of the shares, from Futu Securities International Hong Kong.

5 m ago

Torrence Precision Manufacturing Co., Ltd. will be listed on the Shenzhen Stock Exchange on July 10, 2026.

See all latest